» Articles » PMID: 22194975

Pivotal Role of Toll-like Receptors 2 and 4, Its Adaptor Molecule MyD88, and Inflammasome Complex in Experimental Tubule-interstitial Nephritis

Abstract

Tubule-interstitial nephritis (TIN) results in decreased renal function and interstitial inflammation, which ultimately leads to fibrosis. Excessive adenine intake can cause TIN because xanthine dehydrogenase (XDH) can convert this purine into an insoluble compound, which precipitates in the tubuli. Innate immune sensors, such as Toll-like receptors (TLR) and inflammasome complex, play a crucial role in the initiation of inflammation. The aim of this study was to evaluate the roles of TLR-2 and -4, Myd88 and inflammasome complex in an experimental model of TIN. Here, we show that wild-type (WT) mice fed adenine-enriched food exhibited significant renal dysfunction and enhanced cellular infiltration accompanied by collagen deposition. They also presented higher gene and protein expression of pro-inflammatory cytokines. In contrast, TLR-2, -4, MyD88, ASC and Caspase-1 KO mice showed renoprotection associated with expression of inflammatory molecules at levels comparable to controls. Furthermore, treatment of WT animals with allopurinol, an XDH inhibitor, led to reduced levels of uric acid, oxidative stress, collagen deposition and a downregulation of the NF-kB signaling pathway. We concluded that MyD88 signaling and inflammasome participate in the development of TIN. Furthermore, inhibition of XDH seems to be a promising way to therapeutically target the developing inflammatory process.

Citing Articles

Modulation of NLRP3 Inflammasome Activation by QYHT Decoction: Implications for the Treatment of Erectile Dysfunction in Hyperuricemia.

Ge P, Guo Y, Che B, Jin H, Chen L, Chen Z Am J Mens Health. 2025; 19(1):15579883251318307.

PMID: 40007058 PMC: 11863226. DOI: 10.1177/15579883251318307.


A comparative study of postadrenalectomy hyperuricemia and renal impairment in patients with unilateral primary aldosteronism: does histopathology subtype matter?.

Fang C, Hsieh H, Wang S, Huang K, Peng K, Lin Y BMC Nephrol. 2024; 25(1):347.

PMID: 39396977 PMC: 11472553. DOI: 10.1186/s12882-024-03750-4.


Models of gouty nephropathy: exploring disease mechanisms and identifying potential therapeutic targets.

Wang L, Zhang X, Shen J, Wei Y, Zhao T, Xiao N Front Med (Lausanne). 2024; 11:1305431.

PMID: 38487029 PMC: 10937455. DOI: 10.3389/fmed.2024.1305431.


The role of innate immunity in diabetic nephropathy and their therapeutic consequences.

Yang M, Zhang C J Pharm Anal. 2024; 14(1):39-51.

PMID: 38352948 PMC: 10859537. DOI: 10.1016/j.jpha.2023.09.003.


cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation.

Liu J, Zhou J, Luan Y, Li X, Meng X, Liao W Cell Commun Signal. 2024; 22(1):22.

PMID: 38195584 PMC: 10775518. DOI: 10.1186/s12964-023-01466-w.


References
1.
Lee S, Kalluri R . Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl. 2010; (119):S22-6. PMC: 4067095. DOI: 10.1038/ki.2010.418. View

2.
Nishino T, Okamoto K, Eger B, Pai E, Nishino T . Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J. 2008; 275(13):3278-89. DOI: 10.1111/j.1742-4658.2008.06489.x. View

3.
Eleftheriadis T, Lawson B . Toll-like receptors and kidney diseases. Inflamm Allergy Drug Targets. 2009; 8(3):191-201. DOI: 10.2174/187152809788680985. View

4.
Gill P, Wilcox C . NADPH oxidases in the kidney. Antioxid Redox Signal. 2006; 8(9-10):1597-607. DOI: 10.1089/ars.2006.8.1597. View

5.
Pritsos C . Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system. Chem Biol Interact. 2001; 129(1-2):195-208. DOI: 10.1016/s0009-2797(00)00203-9. View